Back to Search
ERIC BLEICKARDT, MD
MD
Hematology & Oncology Physician
NPI: 1265746879Individual
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
040426(CT)
Research & Publications (7)
Dasatinib-associated major molecular responses in patients with chronic myeloid leukemia in chronic phase following imatinib failure: response dynamics and predictive value.
PMID 19641527·Leukemia·2009
8-other
Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia resistant to imatinib at a dose of 400 to 600 milligrams daily: two-year follow-up of a randomized phase 2 study (START-R).
PMID 19536906·Cancer·2009
3-trial
Dasatinib early intervention after cytogenetic or hematologic resistance to imatinib in patients with chronic myeloid leukemia.
PMID 19402171·Cancer·2009
8-other
Transient potent BCR-ABL inhibition is sufficient to commit chronic myeloid leukemia cells irreversibly to apoptosis.
PMID 19061839·Cancer Cell·2008
8-other
Intermittent target inhibition with dasatinib 100 mg once daily preserves efficacy and improves tolerability in imatinib-resistant and -intolerant chronic-phase chronic myeloid leukemia.
PMID 18541900·J Clin Oncol·2008
3-trial
Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias.
PMID 16775234·N Engl J Med·2006
3-trial
Camptothecin and taxane regimens for small-cell lung cancer.
PMID 12375799·Oncology (Williston Park)·2002
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3 HIDDEN BROOK RD
HAMDEN, CT 06518 - Phone
- (203) 287-9246
Quick Facts
- NPI
- 1265746879
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 7
Are you this provider?
Claim Your Profile